Issue 2/2017
Content (9 Articles)
Open Access
Schizophrenia and Other Psychotic Disorders (J Csernansky, Section Editor)
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Seiya Miyamoto, W. Wolfgang Fleischhacker
Schizophrenia and Other Psychotic Disorders (J Csernansky, Section Editor)
Pharmacogenomics of Antipsychotic Drugs
Jian-Ping Zhang, Anil K. Malhotra
Schizophrenia and Other Psychotic Disorders (J Csernansky, Section Editor)
Targeting the Immune System With Pharmacotherapy in Schizophrenia
Jennifer K. Melbourne, Benjamin Feiner, Cherise Rosen, Rajiv P. Sharma
Schizophrenia and Other Psychotic Disorders (J Csernansky, Section Editor)
Exercise Treatments for Psychosis: a Review
Vijay A. Mittal, Teresa Vargas, K. Juston Osborne, Derek Dean, Tina Gupta, Ivanka Ristanovic, Christine I. Hooker, Stewart A. Shankman
Open Access
Substance Use Disorders (FG Moeller, Section Editor)
Hormones and Neuropeptide Receptor Heteromers in the Ventral Tegmental Area. Targets for the Treatment of Loss of Control of Food Intake and Substance Use Disorders
Sergi Ferré
Substance Use Disorders (FG Moeller, Section Editor)
Pregnancy and the Opioid Epidemic
Kelley Saia, Hendree Jones, Mishka Terplan
Substance Use Disorders (FG Moeller, Section Editor)
The ABCD Study of Neurodevelopment: Identifying Neurocircuit Targets for Prevention and Treatment of Adolescent Substance Abuse
James M. Bjork, Lisa K. Straub, Rosellen G. Provost, Michael C. Neale
Substance Use Disorders (FG Moeller, Section Editor)
The Role of 5-HT2a/2c Receptors in Nociception and Opioid Antinociception: a Review of the Preclinical Literature
Kumiko Lippold, William Dewey
Substance Use Disorders (FG Moeller, Section Editor)
Antagonist Treatment for Opioid Dependence: Promise and Hurdles
Evgeny Krupitsky, Elena Blokhina, Edwin Zvartau, George Woody